Blood Group Typing Market by Type, Application, Element Global Trends and Forecast to 2030 Global Blood Group Typing Market Report offers in-depth analysis of the market size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges. Ongoing blood shortages experienced by countries worldwide have supported new blood campaigns and donation drives. For instance, in September 2022, the Health Ministry of India announced a nationwide blood donation campaign to overcome the blood supply and demand disparity in the country. Browse key industry insights spread across 165 pages with 216 market data tables & 18 figures & charts from the report, “Blood Group Typing Market Analysis By Components (Consumables, Instruments, Services), By Technique (PCR-based & Microarray, Assay-based, Next Generation Sequencing {NGS}), By Test Type (Antigen Typing, Antibody Screening & Identification, ABO Tests, Cross-matched Tests), By End-use (Hospitals, Laboratories, Blood Banks), Industry Analysis Report, Regional Outlook Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030”, in detail along with the table of contents: https://www.gminsights.com/industry-analysis/blood-group-typing-market Technological advancements in genetic engineering will advocate the introduction of RBCbased antigen genotyping that relies on next-generation sequencing (NGS) and high-density DNA arrays. In March 2022, Immucor launched MIA FOR A NGS EXPRESS, its latest HLA typing software to provide a value-added user experience to its customers. The new tool is designed to facilitate high-accuracy antigen typing capable of addressing the limitations of existing NGS products used in laboratories. The blood group typing market is categorized into components, technique, test type, enduse, and region. Based on component, the market is fragmented into consumables, services, and instruments. Among these, the service segment is projected to reach over USD 300 million through 2030. The availability of a range of blood group typing services enables accurate and faster analysis with the help of state-of-the-art software technologies. Software-integrated service enhances overall patient experience with improved clinical processes. In terms of technique, the blood group typing industry is classified into next-generation sequencing (NGS), assay-based, PCR-based & microarray, and others. Next-generation sequencing (NGS) segment is expected to exhibit substantial growth from 2022-2030 owing to widespread usage in a variety of tests. NGS helps determine blood group antigens based on certain specific gene sequences. © 2022 All Rights Reserved
www.gminsights.com